Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
K

Kestra Medical Technologies Inc
NASDAQ:KMTS

Watchlist Manager
Kestra Medical Technologies Inc
NASDAQ:KMTS
Watchlist
Price: 27.46 USD -1.4% Market Closed
Market Cap: $1.6B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

KMTS Price Targets Summary
Kestra Medical Technologies Inc

Wall Street analysts forecast KMTS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KMTS is 29.58 USD with a low forecast of 24.24 USD and a high forecast of 33.6 USD.

KMTS Lowest Forecast
Wall Street Target
24.24 USD
-12% Downside
KMTS Average Forecast
Wall Street Target
29.58 USD
8% Upside
KMTS Highest Forecast
Wall Street Target
33.6 USD
22% Upside
Lowest
Price Target
24.24 USD
12% Downside
Average
Price Target
29.58 USD
8% Upside
Highest
Price Target
33.6 USD
22% Upside
Kestra Medical Technologies Inc Competitors:
Price Targets
CBAN
Colony Bankcorp Inc
6% Upside
XAIR
Beyond Air Inc
800% Upside
CBAN
Colony Bankcorp Inc
6% Upside
XAIR
Beyond Air Inc
800% Upside

Revenue
Forecast

115% / Year
Past Growth
49% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
115% / Year
Past Growth
49% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 1 year the compound annual growth rate for Kestra Medical Technologies Inc's revenue is 115%. The projected CAGR for the next 3 years is 49%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

What are analyst estimates?

See Also

Summary
KMTS intrinsic value, competitors valuation, and company profile.
DCF Valuation
KMTS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KMTS stock valuation using valuation multiples.
Wall Street Estimates
KMTS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KMTS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KMTS's stock price target?
Price Target
29.58 USD

According to Wall Street analysts, the average 1-year price target for KMTS is 29.58 USD with a low forecast of 24.24 USD and a high forecast of 33.6 USD.

What is Kestra Medical Technologies Inc's Revenue forecast?
Projected CAGR
49%

For the last 1 year the compound annual growth rate for Kestra Medical Technologies Inc's revenue is 115%. The projected CAGR for the next 3 years is 49%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 317,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.